Old Web
English
Sign In
Acemap
>
authorDetail
>
Anca Chelariu-Raicu
Anca Chelariu-Raicu
University of Münster
Medicine
Internal medicine
Ovarian cancer
Oncology
Syndecan 1
4
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract 1237: Biological effects of a FRα-targeting antibody-drug conjugate, IMGN853 (mirvetuximab soravtansine) in high-grade serous ovarian cancer
2020
Anca Chelariu-Raicu
Elaine Stur
Cristina Ivan
Robert L. Coleman
Anil K. Sood
Wen Yunfei
Show All
Source
Cite
Save
Citations (0)
Anti-Angiogenesis Therapy in Ovarian Cancer: Which Patient is It Most Likely to Benefit?
2019
Oncology
Anca Chelariu-Raicu
Robert L. Coleman
Anil K. Sood
Show All
Source
Cite
Save
Citations (12)
Diamonds in the rough: An analysis of complete pathologic responders in ovarian cancer
2019
Gynecologic Oncology
Christopher J. Lafargue
Nicole D. Fleming
Alpa M. Nick
Anca Chelariu-Raicu
Bryan Fellman
T. Castellano
A. Ogasawara
Marianne S. Hom
Erin A. Blake
A.K. Crim
S.N. Westin
Robert L. Coleman
Keitaro Matsuo
Kosei Hasegawa
Kathleen N. Moore
Anil K. Sood
Show All
Source
Cite
Save
Citations (0)
Syndecan-4 expression is upregulated in endometriosis and contributes to an invasive phenotype
2016
Fertility and Sterility
Anca Chelariu-Raicu
Cornelia Wilke
Melanie Brand
Anna Starzinski-Powitz
L. Kiesel
Andreas N. Schüring
Martin Götte
Show All
Source
Cite
Save
Citations (12)
1